Imidlertid antyder de begrænsede data fra et fase IIa studie af HIV- smittede patienter, at der ikke kan forventes signifikant interaktion mellem nevirapin og APTIVUS givet sammen med lavdosis ritonavir.
However, the limited data available from a phase IIa study in HIV-infected patients suggest that no significant interaction is expected between nevirapine and APTIVUS co-administered with low dose ritonavir.